GlassScriptPhysician profile
Tiffany Eady
NPI 1649512435
$1,751.63
in general payments reported to CMS, 2019-2025
10 companies · $88.62 in 2025
The $88.62 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $31.42 · 2021: $218 · 2022: $65.25 · 2023: $1,137 · 2025: $88.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $758 · Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $758.07 |
| Food and Beverage | $468.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $1,119.60 | 2023 | |
| Ucb, INC. | $335.59 | 2019-2023 | Briviact |
| Eisai INC. | $90.55 | 2021-2025 | |
| Abbvie INC. | $50.35 | 2022-2025 | |
| Amgen INC. | $50.04 | 2019-2021 | |
| Abbott Laboratories | $32.13 | 2025 | Amplatzer Talisman |
| Sk Life Science, INC. | $23.89 | 2021 | |
| Greenwich Biosciences, INC. | $18.94 | 2019 | |
| Lilly USA, LLC | $15.76 | 2021 | |
| Allergan, INC. | $14.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Eady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.